Body WeightSUB-POPNCT04567108
Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water
A study testing Maintain usual SSBs, Substitute to non-SSBs and Study app in people with Body Weight, run by Brigham and Women's Hospital at 1 site in United States.
Trial summary
Sugar-sweetened beverages (SSBs) contribute an alarming ~7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Read more about this study
- Who is it for?
- Ages 20 to 69 yearsHealthy volunteers can take part
- Conditions the study is for
- Body Weight
- What is being tested?
- Maintain usual SSBs, Substitute to non-SSBs and Study app
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 461 participants
- Where
- 1 siteUnited States
- Study dates
- 22 Apr 2021to 21 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 69 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adults aged 20-69 years
- Consume ≥1 serving/day (12 oz.) of SSBs (SSBs include soda, fruit drinks, energy drinks, sports drinks, and sweetened waters, sweetened with high fructose corn syrup, sucrose, or fruit juices. SSBs do not include 100% fruit juice, sweetened teas, or flavored milk.)
- BMI 25.0 to 45.0 kg/m2
- Access to a smartphone and willingness and ability to download study app
- Willing to consume beverages consistent with any of the 4 possible group assignments for 6 months
Who cannot join
- Physician diagnosis of T2D or fasting glucose ≥126 mg/dL at in-person screening visit
- Intention to move away from greater Boston area within 1 year from randomization
- Major medical illness (known cardiovascular disease, cancer, kidney disease, cirrhosis, etc.)
- Phenylketonuria (PKU)
- Medication that may affect weight or other study endpoints
- Another family or household member participating in the study
- Pregnant in the past 12 months, currently breastfeeding, or planning to become pregnant during the study period
Trial locations and contacts
1 site in 1 country.
United States1 site
Brigham and Women's Hospital
Boston, Massachusetts, 02215
About this study
Official title: SUBstituting With Preferred Options: Health Effects of Substituting Sugar-sweetened Beverages With Non-caloric Beverages in Adults With Overweight and Obesity
Sugar-sweetened beverages (SSBs) contribute an alarming ~7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Therefore, the investigators will conduct a 4-arm randomized diet intervention trial to test the effects of substituting SSBs with calorie-free alternatives on body weight and health, among habitual SSB consumers with overweight/obesity.
Read the detailed description
The SUBstituting with Preferred OPtions (SUB-POP) trial, is a parallel-arm randomized controlled trial (RCT) to test the effects of substituting SSBs with non-caloric options on body weight and markers of type 2 diabetes and cardiometabolic health. Eligible adult participants will be randomized to 1 of 4 beverage groups and receive at-home monthly deliveries of beverages for 6 months. In-person clinic visits will be conducted at baseline, 6, and 12 months. After the 6 months of assigned beverage substitution and delivery, all participants will be instructed to substitute SSBs with water only for a final 6-month observational period. In-person clinic visits will collect technician-measured anthropometrics, blood pressure, biospecimen samples (blood, urine, stool [subset]), and assess physical activity, diet, beverage frequency, and taste preference. The SUB-POP app-based assessments and online diet recall will ascertain daily beverage intake, while diet (via 3 24-hour recalls), physical activity, and overall beverage frequency will be collected every 1-3 months. A subset will receive at-home digital scales to transmit daily body weight for energy balance and caloric compensation modeling. SUB-POP is a novel RCT that will enroll adult regular SSB consumers with overweight or obesity to evaluate the effectiveness of substituting SSBs with non-caloric options in a real-world, un-blinded setting. The trial will leverage social media recruitment methods, achieve ≥30% non-White participants, implement innovative intervention delivery, adherence, and data collection tools, and partition the artificially-sweetened beverage (ASB) substitution intervention to the two most common artificial sweetener types (aspartame, sucralose) to explore potential heterogeneity. Whether ASBs, which are largely free of calories and sugar, provide a healthful interim strategy to transition to water among habitual SSB consumers is unknown. Thus, by addressing this large gap in the understanding of how to address a highly prevalent and concerning dietary exposure, the investigators will inform dietary guidelines and clinical recommendations for the prevention of obesity, type 2 diabetes, and cardiometabolic disease risks. The primary outcomes are change in body weight from baseline to 6 months between the 3 beverage substitution groups (aspartame ASBs, sucralose ASBs, and water) vs. the maintain SSBs control group, adjusting for multiple comparisons. The investigators and staff will be blinded to group assignment at outcome assessments. Intention-to-treat analysis will be used.
After 9/1/2023 the 2 ASB intervention groups (sucralose, aspartame) are combined into a single ASB intervention group; participants randomized on or after 9/1/2023 will be randomized to 1 of 3 beverage groups: maintain SSBs (months 0-6; then switch to water months 6-12); switch to ASBs (months 0-6; then switch to water months 6-12); switch to water (months 0-12). The primary outcomes are change in body weight from baseline to 6 months between the 2 beverage substitution groups (ASBs [all ASB intervention groups combined] and water) vs. the maintain SSBs control group, adjusting for multiple comparisons.
- Conditions
- Body Weight
- Being tested
- Maintain usual SSBs, Substitute to non-SSBs, Study app, Beverage delivery
- Keywords
- Prevention, Weight control, Sugar-sweetened beverages, Artificial sweeteners, Water, Beverages
- Medical subject headings
- Body Weight
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Maintain usual SSBsBehavioural
Instruction/guidelines to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)
Substitute to non-SSBsBehavioural
Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)
Study appBehavioural
Engage with a motivational mobile app to track beverage intake and complete study data collection
Beverage deliveryBehavioural
Select from approved beverages for a monthly at-home delivery (months 0-6)
| Study group | Role | What they receive |
|---|---|---|
| Maintain SSBs (Control) | Active comparator | Instruction to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12) Receives: Behavioral: Maintain usual SSBs; Behavioral: Study app; Behavioral: Beverage delivery |
| Substitute Aspartame ASBs (participants randomized through 8/31/2023) | Experimental | Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with aspartame (months 0-6); then switch to water only (months 6-12) Receives: Behavioral: Substitute to non-SSBs; Behavioral: Study app; Behavioral: Beverage delivery |
| Substitute Sucralose ASBs (participants randomized through 8/31/2023) | Experimental | Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with sucralose (months 0-6); then switch to water only (months 6-12) Receives: Behavioral: Substitute to non-SSBs; Behavioral: Study app; Behavioral: Beverage delivery |
| Substitute Water | Experimental | Instruction/guidelines to eliminate SSBs and replace with water (months 0-12) Receives: Behavioral: Substitute to non-SSBs; Behavioral: Study app; Behavioral: Beverage delivery |
| Substitute ASBs (participants randomized on or after 9/1/2023) | Experimental | Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with choice of non-nutritive sweeteners such as sucralose or aspartame Receives: Behavioral: Substitute to non-SSBs; Behavioral: Study app; Behavioral: Beverage delivery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Weight Change at 6 months
Change in total body weight calculated as the month 6 weight minus the baseline weight
Measured: Baseline, Month 6
Secondary outcomes (9)
Waist Circumference Change
Calculated as month 6 minus baseline value
Measured: Baseline, Month 6
Sussex Sweet Taste Preference Score Change (0 to 100 where higher score indicates greater liking of sweet taste)
Calculated as month 6 minus baseline value
Measured: Baseline, Month 6
Beverage Intake Change (oz/d)
Calculated as month 6 minus baseline value
Measured: Baseline, Month 6
Fasting Plasma Glucose Change
Calculated as month 6 minus baseline value
Measured: Baseline, Month 6
Fasting Blood Insulin Change
Calculated as month 6 minus baseline value
Measured: Baseline, Month 6
HOMA-IR Change
Calculated as month 6 minus baseline value
Measured: Baseline, Month 6
HbA1c Change
Calculated as month 6 minus baseline value
Measured: Baseline, Month 6
TG/HDL Ratio Change
Calculated as month 6 minus baseline value
Measured: Baseline, Month 6
Weight Change Sustainability
Calculated as month 6 minus baseline value, month 12 minus month 6 value
Measured: Baseline, Month 6
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2020
- Study start22 Apr 2021
- Primary completion21 May 2026
- Study completion21 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Body WeightStudies of the same condition, open and under way.
- More trials run by Brigham and Women's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Parallel randomization on a rolling basis to one of 4 interventions; After 9/1/2023 design is modified to 3 parallel interventions, with sucralose and aspartame interventions combined into one ASB substitution arm
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 461 participants (actual)
Sponsor and investigators
- Lead sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Deirdre K Tobias, ScD, Brigham and Women's Hospital
- Investigators
- Deirdre Tobias, ScD, Principal investigator, Brigham and Women's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04567108
- Sponsor's protocol ID
- 2020p002494
- Other IDs
- 1R01DK125803-01
- Acronym
- SUB-POP
- Status last verified
- Jul 2026
- First submitted
- 14 Sep 2020
- Last updated
- 17 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- SUBstituting With Preferred Options: Health Effects of Substituting Sugar-sweetened Beverages With Non-caloric Beverages in Adults With Overweight and Obesity
- ClinicalTrials.gov ID
- NCT04567108
- Acronym / sponsor ID
- SUB-POP / 2020p002494
- Conditions
- Body Weight
- Keywords
- Prevention, Weight control, Sugar-sweetened beverages, Artificial sweeteners, Water, Beverages
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 461 participants (actual)
- Lead sponsor
- Brigham and Women's HospitalUniversity, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study start
- 22 Apr 2021 (actual)
- Primary completion
- 21 May 2026 (actual)
- Study completion
- 21 May 2026 (actual)
- First posted
- 28 Sep 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sugar-sweetened beverages (SSBs) contribute an alarming ~7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Therefore, the investigators will conduct a 4-arm randomized diet intervention trial to test the effects of substituting SSBs with calorie-free alternatives on body weight and health, among habitual SSB consumers with overweight/obesity.
Detailed description
The SUBstituting with Preferred OPtions (SUB-POP) trial, is a parallel-arm randomized controlled trial (RCT) to test the effects of substituting SSBs with non-caloric options on body weight and markers of type 2 diabetes and cardiometabolic health. Eligible adult participants will be randomized to 1 of 4 beverage groups and receive at-home monthly deliveries of beverages for 6 months. In-person clinic visits will be conducted at baseline, 6, and 12 months. After the 6 months of assigned beverage substitution and delivery, all participants will be instructed to substitute SSBs with water only for a final 6-month observational period. In-person clinic visits will collect technician-measured anthropometrics, blood pressure, biospecimen samples (blood, urine, stool [subset]), and assess physical activity, diet, beverage frequency, and taste preference. The SUB-POP app-based assessments and online diet recall will ascertain daily beverage intake, while diet (via 3 24-hour recalls), physical activity, and overall beverage frequency will be collected every 1-3 months. A subset will receive at-home digital scales to transmit daily body weight for energy balance and caloric compensation modeling. SUB-POP is a novel RCT that will enroll adult regular SSB consumers with overweight or obesity to evaluate the effectiveness of substituting SSBs with non-caloric options in a real-world, un-blinded setting. The trial will leverage social media recruitment methods, achieve ≥30% non-White participants, implement innovative intervention delivery, adherence, and data collection tools, and partition the artificially-sweetened beverage (ASB) substitution intervention to the two most common artificial sweetener types (aspartame, sucralose) to explore potential heterogeneity. Whether ASBs, which are largely free of calories and sugar, provide a healthful interim strategy to transition to water among habitual SSB consumers is unknown. Thus, by addressing this large gap in the understanding of how to address a highly prevalent and concerning dietary exposure, the investigators will inform dietary guidelines and clinical recommendations for the prevention of obesity, type 2 diabetes, and cardiometabolic disease risks. The primary outcomes are change in body weight from baseline to 6 months between the 3 beverage substitution groups (aspartame ASBs, sucralose ASBs, and water) vs. the maintain SSBs control group, adjusting for multiple comparisons. The investigators and staff will be blinded to group assignment at outcome assessments. Intention-to-treat analysis will be used.
After 9/1/2023 the 2 ASB intervention groups (sucralose, aspartame) are combined into a single ASB intervention group; participants randomized on or after 9/1/2023 will be randomized to 1 of 3 beverage groups: maintain SSBs (months 0-6; then switch to water months 6-12); switch to ASBs (months 0-6; then switch to water months 6-12); switch to water (months 0-12). The primary outcomes are change in body weight from baseline to 6 months between the 2 beverage substitution groups (ASBs [all ASB intervention groups combined] and water) vs. the maintain SSBs control group, adjusting for multiple comparisons.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 5
- Model description
- Parallel randomization on a rolling basis to one of 4 interventions; After 9/1/2023 design is modified to 3 parallel interventions, with sucralose and aspartame interventions combined into one ASB substitution arm
| Arm | Type | Receives |
|---|---|---|
| Maintain SSBs (Control) | Active comparator | Behavioral: Maintain usual SSBs, Behavioral: Study app, Behavioral: Beverage deliveryInstruction to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12) |
| Substitute Aspartame ASBs (participants randomized through 8/31/2023) | Experimental | Behavioral: Substitute to non-SSBs, Behavioral: Study app, Behavioral: Beverage deliveryInstruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with aspartame (months 0-6); then switch to water only (months 6-12) |
| Substitute Sucralose ASBs (participants randomized through 8/31/2023) | Experimental | Behavioral: Substitute to non-SSBs, Behavioral: Study app, Behavioral: Beverage deliveryInstruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with sucralose (months 0-6); then switch to water only (months 6-12) |
| Substitute Water | Experimental | Behavioral: Substitute to non-SSBs, Behavioral: Study app, Behavioral: Beverage deliveryInstruction/guidelines to eliminate SSBs and replace with water (months 0-12) |
| Substitute ASBs (participants randomized on or after 9/1/2023) | Experimental | Behavioral: Substitute to non-SSBs, Behavioral: Study app, Behavioral: Beverage deliveryInstruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with choice of non-nutritive sweeteners such as sucralose or aspartame |
Who may qualify
- Ages
- 20 to 69 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Adults aged 20-69 years
- Consume ≥1 serving/day (12 oz.) of SSBs (SSBs include soda, fruit drinks, energy drinks, sports drinks, and sweetened waters, sweetened with high fructose corn syrup, sucrose, or fruit juices. SSBs do not include 100% fruit juice, sweetened teas, or flavored milk.)
- BMI 25.0 to 45.0 kg/m2
- Access to a smartphone and willingness and ability to download study app
- Willing to consume beverages consistent with any of the 4 possible group assignments for 6 months
Key exclusion criteria (7 listed)
- Physician diagnosis of T2D or fasting glucose ≥126 mg/dL at in-person screening visit
- Intention to move away from greater Boston area within 1 year from randomization
- Major medical illness (known cardiovascular disease, cancer, kidney disease, cirrhosis, etc.)
- Phenylketonuria (PKU)
- Medication that may affect weight or other study endpoints
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Maintain usual SSBsInstruction/guidelines to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12) | Behavioural | Maintain SSBs (Control) |
| Substitute to non-SSBsInstruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12) | Behavioural | Substitute ASBs (participants randomized on or after 9/1/2023), Substitute Aspartame ASBs (participants randomized through 8/31/2023), Substitute Sucralose ASBs (participants randomized through 8/31/2023), Substitute Water |
| Study appEngage with a motivational mobile app to track beverage intake and complete study data collection | Behavioural | Maintain SSBs (Control), Substitute ASBs (participants randomized on or after 9/1/2023), Substitute Aspartame ASBs (participants randomized through 8/31/2023), Substitute Sucralose ASBs (participants randomized through 8/31/2023), Substitute Water |
| Beverage deliverySelect from approved beverages for a monthly at-home delivery (months 0-6) | Behavioural | Maintain SSBs (Control), Substitute ASBs (participants randomized on or after 9/1/2023), Substitute Aspartame ASBs (participants randomized through 8/31/2023), Substitute Sucralose ASBs (participants randomized through 8/31/2023), Substitute Water |
Primary outcome
Weight Change at 6 months
Time frame: Baseline, Month 6
Change in total body weight calculated as the month 6 weight minus the baseline weight
9 secondary outcomes
Waist Circumference Change
Time frame: Baseline, Month 6
Sussex Sweet Taste Preference Score Change (0 to 100 where higher score indicates greater liking of sweet taste)
Time frame: Baseline, Month 6
Beverage Intake Change (oz/d)
Time frame: Baseline, Month 6
Fasting Plasma Glucose Change
Time frame: Baseline, Month 6
Fasting Blood Insulin Change
Time frame: Baseline, Month 6
HOMA-IR Change
Time frame: Baseline, Month 6
HbA1c Change
Time frame: Baseline, Month 6
TG/HDL Ratio Change
Time frame: Baseline, Month 6
Weight Change Sustainability
Time frame: Baseline, Month 6
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Body Weight
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Deirdre Tobias, ScD principal investigator
Brigham and Women's Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Maintain usual SSBs, Substitute to non-SSBs and Study app in people with Body Weight, run by Brigham and Women's Hospital at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Weight Change at 6 months (time frame: Baseline, Month 6). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.